Found 67 matching trials
Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (P08607, MK-3641-006) PHASE4 The purpose of this study is to assess the safety and tolerability of MK-36...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis PHASE2 The purpose of this study is to assess the efficacy of two doses of subling...
Show More Location
Multiple Locations
Learn More & Join Trial
Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract PHASE2 Prospective, randomised, double-blind, placebo-controlled clinical trial to...
Show More Learn More & Join Trial
Exposure Chamber Trial With Cat Immunotherapy PHASE2 The main purpose of this trial is to investigate if any of three different ...
Show More Learn More & Join Trial
Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis PHASE3 The purpose of this 2-year study is to assess the sustained clinical effica...
Show More Location
Alergologicka ordinace
Learn More & Join Trial
Tolerability of SLIT With LAIS® Mites Allergoid Tablets N/A To expand knowledge on the application and tolerability of immunotherapy wi...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05234) PHASE2 This study will evaluate the efficacy and safety of ragweed sublingual tabl...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase 2 Study in Adults Sensitized to Short Ragweed PHASE2 The purpose of this study is to identify an effective dose of allergen-spec...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067) PHASE3 This is a study to evaluate the efficacy and safety of grass sublingual tab...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008) PHASE3 The purpose of this study is to assess the efficacy and safety of short rag...
Show More Location
Multiple Locations
Learn More & Join Trial